Lipid peroxidation: Pathophysiological and pharmacological implications in the eye

Frontiers in Physiology

Volumn 4 DEC, Issue , 2013, Pages

  Njie Mbye, Ya Fatou ^a   Kulkarni Chitnis, Madhura ^a   Opere, Catherine A ^b   Barrett, Aaron ^b   Ohia, Sunny E ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY   (United States)

Author keywords

Lipid peroxidation; Ocular diseases; Oxidative stress; Peroxides

Indexed keywords

AMINO ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOPAMINE; FREE RADICAL; GLUTAMIC ACID; GLYCINE; HYDROGEN PEROXIDE; HYDROXYL GROUP; ISOPROSTANE DERIVATIVE; LONG CHAIN FATTY ACID; MEMBRANE LIPID; NEUROPROSTANE; NEUROTRANSMITTER; NORADRENALIN; OXYGEN; PEROXIDE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

CATARACT; CELL DEATH; DEFENSE MECHANISM; DIABETIC RETINOPATHY; DISEASE COURSE; DOPAMINE RELEASE; EYE DISEASE; GLAUCOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; IRIS; LIPID PEROXIDATION; NORADRENALIN RELEASE; OXIDATIVE STRESS; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SYMPATHETIC NERVE; VISUAL FIELD DEFECT;

EID: 84891711746     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00366     Document Type: Review

References (125)

1. Collaborative Normal-Tension Glaucoma Study Group. (1998). Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 126, 487-497. doi: 10.1016/S0002-9394(98)00223-2.
2. The AGIS Investigators. (2000). The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130, 429-440. doi: 10.1016/S0002-9394(00)00538-9.
3. Age-Related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 119, 1417-1436. doi: 10.1001/archopht.119.10.1417.
4. Al-Shabrawey, M., and Smith, S. (2010). Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers. EPMA J. 1, 56-72. doi: 10.1007/s13167-010-0002-9.
5. Alvarado, J., Murphy, C., and Juster, R. (1984). Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 91, 564-579. doi: 10.1016/S0161-6420(84)34248-8.
6. Alvarado, J., Murphy, C., Polansky, J., and Juster, R. (1981). Age-related changes in trabecular meshwork cellularity. Invest. Ophthalmol. Vis. Sci. 21, 714-727.
7. Atilano, S. R., Chwa, M., Kim, D. W., Jordan, N., Udar, N., Coskun, P., et al. (2009). Hydrogen peroxide causes mitochondrial DNA damage in corneal epithelial cells. Cornea 28, 426-433. doi: 10.1097/ICO.0b013e31818c2c55.
8. Awe, S. O., Opere, C. A., Harris, L. C., Uketui, A. J., and Ohia, S. E. (2000). Effect of isoprostanes on sympathetic neurotransmission in the human isolated iris-ciliary body. Neurochem. Res. 25, 491-496. doi: 10.1023/A:1007560025570.
9. Babizhayev, M. A., and Bunin, A. Y. (1989). Lipid peroxidation in open-angle glaucoma. Acta Ophthalmol. (Copenh.) 67, 371-377. doi: 10.1111/j.1755-3768.1989.tb01617.x.
10. Beatty, S., Koh, H., Phil, M., Henson, D., and Boulton, M. (2000). The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45, 115-134. doi: 10.1016/S0039-6257(00)00140-5.
11. Berthoud, V. M., and Beyer, E. C. (2009). Oxidative stress, lens gap junctions, and cataracts. Antioxid. Redox Signal. 11, 339-353. doi: 10.1089/ars.2008.2119.
12. Bertram, K. M., Baglole, C. J., Phipps, R. P., and Libby, R. T. (2009). Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. Am. J. Physiol. Cell Physiol. 297, C1200-C1210. doi: 10.1152/ajpcell.00126.2009.
13. Birnbaum, D., Csukas, S., Costarides, A., Forbes, E., and Green, K. (1987). 3-amino-triazole effects on the eye of young and adult rabbits in the presence and absence of hydrogen peroxide. Curr. Eye Res. 6, 1403-1414. doi: 10.3109/02713688709044504.
14. Blokhina, O., Virolainen, E., and Fagerstedt, K. V. (2003). Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann. Bot. 91, 179-194. doi: 10.1093/aob/mcf118.
15. Brennan, L. A., and Kantorow, M. (2009). Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations. Exp. Eye Res. 88, 195-203. doi: 10.1016/j.exer.2008.05.018.
16. Bruban, J., Glotin, A. L., Dinet, V., Chalour, N., Sennlaub, F., Jonet, L., et al. (2009). Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 8, 162-177. doi: 10.1111/j.1474-9726.2009.00456.x.
17. Centers for Disease Control and Prevention. (2013). Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion. Vision Health Initiative (VHI). Common Eye Disorders. Available online at: http://www.cdc.gov/visionhealth/basic_information/eye_disorders.htm. Accessed April 23, 2013-Present.
18. Chaudhary, P., Ahmed, F., Quebada, P., and Sharma, S. C. (1999). Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res. Mol. Brain Res. 67, 36-45. doi: 10.1016/S0169-328X(99)00032-7.
19. Cheung, N., Mitchell, P., and Wong, T. Y. (2010). Diabetic retinopathy. Lancet 376, 124-136. doi: 10.1016/S0140-6736(09)62124-3.
20. Chiu, C. J., Milton, R. C., Klein, R., Gensler, G., and Taylor, A. (2007). Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 86, 1210-1218. Available online at: http://ajcn.nutrition.org/content/86/4/1210.long.
21. Chow, C. K., Ibrahim, W., Wei, Z., and Chan, A. C. (1999). Vitamin E regulates mitochondrial hydrogen peroxide generation. Free Radic. Biol. Med. 27, 580-587. doi: 10.1016/S0891-5849(99)00121-5.
22. Costarides, A. P., Riley, M. V., and Green, K. (1991). Roles of catalase and the glutathione redox cycle in the regulation of anterior-chamber hydrogen peroxide. Ophthalmic Res. 23, 284-294. doi: 10.1159/000267124.
23. Cracowski, J. L., Durand, T., and Bessard, G. (2002). Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol. Sci. 23, 360-366. doi: 10.1016/S0165-6147(02)02053-9.
24. Csukas, S. C., and Green, K. (1988). Effects of intracameral hydrogen peroxide in the rabbit anterior chamber. Invest. Ophthalmol. Vis. Sci. 29, 335-339.
25. Cui, Q., Tang, L. S., Hu, B., So, K. F., and Yip, H. K. (2002). Expression of trkA, trkB, and trkC in injured and regenerating retinal ganglion cells of adult rats. Invest. Ophthalmol. Vis. Sci. 43, 1954-1964. Available online at: http://www.iovs.org/content/43/6/1954.long.
26. De, C. R., Cybulsky, M. I., Clinton, S. K., Gimbrone, M. A. Jr., and Libby, P. (1994). The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 14, 1829-1836. doi: 10.1161/01.ATV.14.11.1829.
27. Delanty, N., Reilly, M. P., Pratico, D., Lawson, J. A., McCarthy, J. F., Wood, A. E., et al. (1997). 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95, 2492-2499. doi: 10.1161/01.CIR.95.11.2492.
28. Dentchev, T., Yao, Y., Pratico, D., and Dunaief, J. (2007). Isoprostane F2alpha-VI, a new marker of oxidative stress, increases following light damage to the mouse retina. Mol. Vis. 13, 190-195.
29. Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., and Ferrington, D. A. (2007). Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest. Ophthalmol. Vis. Sci. 48, 3469-3479. doi: 10.1167/iovs.06-1058.
30. Fam, S. S., Murphey, L. J., Terry, E. S., Zackert, W. E., Chen, Y., Gao, L., et al. (2002). Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 277, 36076-36084. doi: 10.1074/jbc.M205638200.
31. Ferreira, S. M., Lerner, S. F., Brunzini, R., Evelson, P. A., and Llesuy, S. F. (2004). Oxidative stress markers in aqueous humor of glaucoma patients. Am. J. Ophthalmol. 137, 62-69. doi: 10.1016/S0002-9394(03)00788-8.
32. Gao, H., Qiao, X., Hefti, F., Hollyfield, J. G., and Knusel, B. (1997). Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest. Ophthalmol. Vis. Sci. 38, 1840-1847.
33. Gherghel, D., Griffiths, H. R., Hilton, E. J., Cunliffe, I. A., and Hosking, S. L. (2005). Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46, 877-883. doi: 10.1167/iovs.04-0777.
34. Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., and Offen, D. (2002). Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 54, 271-284. doi: 10.1124/pr.54.2.271.
35. Gopaul, N. K., Anggard, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., and Nourooz-Zadeh, J. (1995). Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:225-229. doi: 10.1016/0014-5793(95)00649-T.
36. Graham, J., Awe, S. O., LeDay, A. M., et al. (2000). Effect of inhibition of cyclooxygenase on pre-and postjunctional actions of peroxides in the iris-ciliary body. Neurochem. Res. 25, 519-525. doi: 10.1023/A:1007568227387.
37. Green, K. (1995). Free radicals and aging of anterior segment tissues of the eye: a hypothesis. Ophthalmic Res. 27(Suppl. 1), 143-149. doi: 10.1159/000267860.
38. Greene, E. L., and Paller, M. S. (1992). Xanthine oxidase produces O2-. in posthypoxic injury of renal epithelial cells. Am. J. Physiol. 263, F251-F255.
39. Grierson, I., and Howes, R. C. (1987). Age-related depletion of the cell population in the human trabecular meshwork. Eye (Lond.) 1(Pt 2), 204-210. doi: 10.1038/eye.1987.38.
40. Grierson, I., Howes, R. C., and Wang, Q. (1984). Age-related changes in the canal of Schlemm. Exp. Eye Res. 39, 505-512. doi: 10.1016/0014-4835(84)90050-2.
41. Grimble, R. F. (1998). Dietary lipids and the inflammatory response. Proc. Nutr. Soc. 57, 535-542. doi: 10.1079/PNS19980078.
42. Gurler, B., Vural, H., Yilmaz, N., Oguz, H., Satici, A., and Aksoy, N. (2000). The role of oxidative stress in diabetic retinopathy. Eye (Lond.) 14(Pt 5), 730-735. doi: 10.1038/eye.2000.193.
43. Hollyfield, J. G. (2010). Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture. Invest. Ophthalmol. Vis. Sci. 51, 1275-1281. doi: 10.1167/iovs.09-4478.
44. Hollyfield, J. G., Bonilha, V. L., Rayborn, M. E., Yang, X., Shadrach, K. G., Lu, L., et al. (2008). Oxidative damage induced inflammation initiates age-related macular degeneration. Nat. Med. 14, 194-198. doi: 10.1038/nm1709.
45. Hou, X., Roberts, L. J., Gobeil, F., Jr., et al. (2004). Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic. Biol. Med. 36, 163-172. doi: 10.1016/j.freeradbiomed.2003.10.024.
46. Huang, W., Fileta, J. B., Filippopoulos, T., Ray, A., Dobberfuhl, A., and Grosskreutz, C. L. (2007). Hsp27 phosphorylation in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 48, 4129-4135. doi: 10.1167/iovs.06-0606.
47. Izzotti, A., Bagnis, A., and Sacca, S. C. (2006). The role of oxidative stress in glaucoma. Mutat. Res. 612, 105-114. doi: 10.1016/j.mrrev.2005.11.001.
48. Izzotti, A., Sacca, S. C., Longobardi, M., and Cartiglia, C. (2009). Sensitivity of ocular anterior chamber tissues to oxidative damage and its relevance to the pathogenesis of glaucoma. Invest. Ophthalmol. Vis. Sci. 50, 5251-5258. doi: 10.1167/iovs.09-3871.
49. Jamil, J., Wright, A., Harrison, N., et al. (2012). Regulation of [(3)H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina. Neurochem. Res. 37, 574-582. doi: 10.1007/s11064-011-0645-5.
50. Jarrett, S. G., and Boulton, M. E. (2012). Consequences of oxidative stress in age-related macular degeneration. Mol. Aspects Med. 33, 399-417. doi: 10.1016/j.mam.2012.03.009.
51. Jarvinen, T., Pate, D. W., and Laine, K. (2002). Cannabinoids in the treatment of glaucoma. Pharmacol. Ther. 95, 203-220. doi: 10.1016/S0163-7258(02)00259-0.
52. Jayle, G. E., Aubry, M., Gavini, H., Braccini, G., and De la Baume, C. (1965). [Study concerning the action of anthocyanoside extracts of Vaccinium Myrtillus on night vision]. Ann. Ocul. (Paris) 198, 556-562.
53. Jin, X. H., Ohgami, K., Shiratori, K., Koyama, Y., Yoshida, K., Kase, S., et al. (2007). Inhibition of nuclear factor-kappa B activation attenuates hydrogen peroxide-induced cytotoxicity in human lens epithelial cells. Br. J. Ophthalmol. 91, 369-371. doi: 10.1136/bjo.2006.107037.
54. Kahn, M. G., Giblin, F. J., and Epstein, D. L. (1983). Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility. Invest. Ophthalmol. Vis. Sci. 24, 1283-1287.
55. Kaiser, N., Sasson, S., Feener, E. P., Boukobza-Vardi, N., Higashi, S., Moller, D. E., et al. (1993). Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42, 80-89. doi: 10.2337/diab.42.1.80.
56. Kang, J. H., Pasquale, L. R., Willett, W., Rosner, B., Egan, K. M., Faberowski, N., et al. (2003). Antioxidant intake and primary open-angle glaucoma: a prospective study. Am. J. Epidemiol. 158, 337-346. doi: 10.1093/aje/kwg167.
57. Kanwar, M., Chan, P. S., Kern, T. S., and Kowluru, R. A. (2007). Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 48, 3805-3811. doi: 10.1167/iovs.06-1280.
58. Kasahara, E., Lin, L. R., Ho, Y. S., and Reddy, V. N. (2005). SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 46, 3426-3434. doi: 10.1167/iovs.05-0344.
59. Ko, M. L., Peng, P. H., Ma, M. C., Ritch, R., and Chen, C. F. (2005). Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic. Biol. Med. 39, 365-373. doi: 10.1016/j.freeradbiomed.2005.03.025.
60. Koliakos, G. G., Konstas, A. G., Schlotzer-Schrehardt, U., Hollo, G., Katsimbris, I. E., Georgiadis, N., et al. (2003). 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br. J. Ophthalmol. 87, 353-356. doi: 10.1136/bjo.87.3.353.
61. Kuusisto, J., Mykkanen, L., Pyorala, K., and Laakso, M. (1994). NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43, 960-967. doi: 10.2337/diab.43.8.960.
62. Lahaie, I., Hardy, P., Hou, X., Hassessian, H., Asselin, P., Lachapelle, P., et al. (1998). A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am. J. Physiol. 274, R1406-R1416.
63. LeDay, A. M., Kulkarni, K. H., Opere, C. A., and Ohia, S. E. (2004). Arachidonic acid metabolites and peroxide-induced inhibition of [3H]D-aspartate release from bovine isolated retinae. Curr. Eye Res. 28, 367-372. doi: 10.1076/ceyr.28.5.367.28675.
64. Levin, L. A., Schlamp, C. L., Spieldoch, R. L., Geszvain, K. M., and Nickells, R. W. (1997). Identification of the bcl-2 family of genes in the rat retina. Invest. Ophthalmol. Vis. Sci. 38, 2545-2553.
65. Li, L., Duker, J. S., Yoshida, Y., Niki, E., Rasmussen, H., Russell, R., et al. (2009). Oxidative stress and antioxidant status in older adults with early cataract. Eye (Lond.) 23, 1464-1468. doi: 10.1038/eye.2008.281.
66. Liles, M. R., Newsome, D. A., and Oliver, P. D. (1991). Antioxidant enzymes in the aging human retinal pigment epithelium. Arch. Ophthalmol. 109, 1285-1288. doi: 10.1001/archopht.1991.01080090111033.
67. Liu, H., Zhao, M., and Opere, C. A. (2008). Prejunctional inhibitory effects of isoprostanes on dopaminergic neurotransmission in bovine retinae, in vitro. Neurochem. Res. 33, 37-42. doi: 10.1007/s11064-007-9404-z.
68. Ma, W., Li, D., Sun, F., Kleiman, N. J., and Spector, A. (2004). The effect of stress withdrawal on gene expression and certain biochemical and cell biological properties of peroxide-conditioned cell lines. FASEB J. 18, 480-488. doi: 10.1096/fj.03-0732com.
69. Madsen-Bouterse, S. A., and Kowluru, R. A. (2008). Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev. Endocr. Metab. Disord. 9, 315-327. doi: 10.1007/s11154-008-9090-4.
70. Mainster, M. A. (1987). Light and macular degeneration: a biophysical and clinical perspective. Eye (Lond.) 1(Pt 2), 304-310. doi: 10.1038/eye.1987.49.
71. Majumdar, S., and Srirangam, R. (2010). Potential of the bioflavonoids in the prevention/treatment of ocular disorders. J. Pharm. Pharmacol. 62, 951-965.
72. Malone, P. E., and Hernandez, M. R. (2007). 4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes. Exp. Eye Res. 84, 444-454. doi: 10.1016/j.exer.2006.10.020.
73. Matutte, B., Awe, S. O., Ameh, F. A., LeDay, A. M., Rice, J. C., Opere, C. A., et al. (2000). Role of catalase in pre-and postjunctional responses of mammalian irides to hydrogen peroxide. J. Ocul. Pharmacol. Ther. 16, 429-438. doi: 10.1089/jop.2000.16.429.
74. Morrow, J. D. (2000). The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab. Rev. 32, 377-385. doi: 10.1081/DMR-100102340.
75. Morrow, J. D. (2006). The isoprostanes-unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr. Pharm. Des. 12, 895-902. doi: 10.2174/138161206776055985.
76. M., Yoshida, Y., Kaidzu, S., Ohira, A., and Niki, E. (2006). Detection of lipid peroxidation in light-exposed mouse retina assessed by oxidative stress markers, total hydroxyoctadecadienoic acid and 8-iso-prostaglandin F2alpha. Neurosci. Lett. 398, 63-68. doi: 10.1016/j.neulet.2005.12.070.
77. Nourooz-Zadeh, J., and Pereira, P. (2000). F(2) isoprostanes, potential specific markers of oxidative damage in human retina. Ophthalmic Res. 32, 133-137. doi: 10.1159/000055603.
78. Nucci, C., Tartaglione, R., Rombola, L., Morrone, L. A., Fazzi, E., and Bagetta, G. (2005). Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26, 935-941. doi: 10.1016/j.neuro.2005.06.002.
79. O'Connell, E. D., Nolan, J. M., Stack, J., Greenberg, D., Kyle, J., Maddock, L., et al. (2008). Diet and risk factors for age related maculopathy. Am. J. Clin. Nutr. 87, 712-722.
80. Ohia, S. E., Opere, C. A., and LeDay, A. M. (2005). Pharmacological consequences of oxidative stress in ocular tissues. Mutat. Res. 579, 22-36. doi: 10.1016/j.mrfmmm.2005.03.025.
81. Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., et al. (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28, 103-117. doi: 10.1016/0168-8227(95)01064-K.
82. Opere, C. A., Awe, S. O., Harris, L. C., LeDay, A. M., and Ohia, S. E. (2001a). Potentiation of sympathetic neurotransmission in bovine isolated irides by isoprostanes. Free Radic. Res. 35, 257-264. doi: 10.1080/10715760100300791.
83. Opere, C. A., Awe, S. O., Harris, L. C., LeDay, A. M., and Ohia, S. E. (2001b). Potentiation of sympathetic neurotransmission in bovine isolated irides by isoprostanes. Free Radic. Res. 35, 257-264. doi: 10.1080/10715760100300791.
84. Opere, C. A., Ford, K., Zhao, M., and Ohia, S. E. (2008). Regulation of neurotransmitter release from ocular tissues by isoprostanes. Methods Find. Exp. Clin. Pharmacol. 30, 697-701. doi: 10.1358/mf.2008.30.9.1323495.
85. Opere, C. A., and Ohia, S. E. (1998). Prejunctional alpha2-adrenoceptors and peroxide-induced potentiation of norepinephrine release from the bovine iris. Neurochem. Res. 23, 1093-1098. doi: 10.1023/A:1020764220449.
86. Opere, C. A., Zheng, W. D., Huang, J., Adewale, A., Kruglet, M., and Ohia, S. E. (2005). Dual effect of isoprostanes on the release of [3H]D-aspartate from isolated bovine retinae: role of arachidonic acid metabolites. Neurochem. Res. 30, 129-137. doi: 10.1007/s11064-004-9694-3.
87. Organisciak, D. T., Darrow, R. M., Barsalou, L., Darrow, R. A., Kutty, R. K., Kutty, G., et al. (1998). Light history and age-related changes in retinal light damage. Invest. Ophthalmol. Vis. Sci. 39, 1107-1116.
88. Osborne, N. N., Ugarte, M., Chao, M., Chidlow, G., Bae, J. H., Wood, J. P., et al. (1999). Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43(Suppl. 1), S102-S128. doi: 10.1016/S0039-6257(99)00044-2.
89. Pan, H. Z., Zhang, H., Chang, D., Li, H., and Sui, H. (2008). The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br. J. Ophthalmol. 92, 548-551. doi: 10.1136/bjo.2007.130542.
90. Parmeggiani, F., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., D'Angelo, S., et al. (2012). Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm. 2012:546786. doi: 10.1155/2012/546786.
91. Porcella, A., Maxia, C., Gessa, G. L., and Pani, L. (2001). The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. Eur. J. Neurosci. 13, 409-412. doi: 10.1046/j.0953-816X.2000.01401.x.
92. Pulido, J. E., Pulido, J. S., Erie, J. C., Arroyo, J., Bertram, K., Lu, M. J., et al. (2007). A role for excitatory amino acids in diabetic eye disease. Exp. Diabetes Res. 2007:36150. doi: 10.1155/2007/36150.
93. Qu, J., Wang, D., and Grosskreutz, C. L. (2010). Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp. Eye Res. 91, 48-53. doi: 10.1016/j.exer.2010.04.002.
94. Rapp, L. M., Maple, S. S., and Choi, J. H. (2000). Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest. Ophthalmol. Vis. Sci. 41, 1200-1209. Available online at: http://www.iovs.org/content/41/5/1200.long.
95. Reich, E. E., Zackert, W. E., Brame, C. J., Chen, Y., Roberts, L. J., Hachey, D. L., et al. (2000). Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry 39, 2376-2383. doi: 10.1021/bi992000l.
96. Resch, H., Garhofer, G., Fuchsjager-Mayrl, G., Hommer, A., and Schmetterer, L. (2009). Endothelial dysfunction in glaucoma. Acta Ophthalmol. 87, 4-12. doi: 10.1111/j.1755-3768.2007.01167.x.
97. Rhee, D. J., Katz, L. J., Spaeth, G. L., and Myers, J. S. (2001). Complementary and alternative medicine for glaucoma. Surv. Ophthalmol. 46, 43-55. doi: 10.1016/S0039-6257(01)00233-8.
98. Riley, M. V. (1990). Physiologic neutralization mechanisms and the response of the corneal endothelium to hydrogen peroxide. CLAO J. 16, S16-S21.
99. Rose, R. C., Richer, S. P., and Bode, A. M. (1998). Ocular oxidants and antioxidant protection. Proc. Soc. Exp. Biol. Med. 217, 397-407. doi: 10.3181/00379727-217-44250.
100. Sacca, S. C., Bolognesi, C., Battistella, A., Bagnis, A., and Izzotti, A. (2009). Gene-environment interactions in ocular diseases. Mutat. Res. 667, 98-117. doi: 10.1016/j.mrfmmm.2008.11.002.
101. Sacca, S. C., Izzotti, A., Rossi, P., and Traverso, C. (2007). Glaucomatous outflow pathway and oxidative stress. Exp. Eye Res. 84, 389-399. doi: 10.1016/j.exer.2006.10.008.
102. Sandbach, J. M., Coscun, P. E., Grossniklaus, H. E., Kokoszka, J. E., Newman, N. J., and Wallace, D. C. (2001). Ocular pathology in mitochondrial superoxide dismutase (Sod2)-deficient mice. Invest. Ophthalmol. Vis. Sci. 42, 2173-2178. Available online at: http://www.iovs.org/content/42/10/2173.long.
103. Sangiovanni, J. P., and Chew, E. Y. (2005). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24, 87-138. doi: 10.1016/j.preteyeres.2004.06.002.
104. Shang, F., Lu, M., Dudek, E., Reddan, J., and Taylor, A. (2003). Vitamin C and vitamin E restore the resistance of GSH-depleted lens cells to H2O2. Free Radic. Biol. Med. 34, 521-530. doi: 10.1016/S0891-5849(02)01304-7.
105. Shichi, H. (2004). Cataract formation and prevention. Expert Opin. Investig. Drugs. 13, 691-701. doi: 10.1517/13543784.13.6.691.
106. Skyler, J. S. (1996). Diabetic complications. The importance of glucose control. Endocrinol. Metab. Clin. North Am. 25, 243-254. doi: 10.1016/S0889-8529(05)70323-6.
107. Sommer, A., Tielsch, J. M., Katz, J., Quigley, H. A., Gottsch, J. D., Javitt, J. C., et al. (1991). Racial differences in the cause-specific prevalence of blindness in east Baltimore. N. Engl. J. Med. 325, 1412-1417. doi: 10.1056/NEJM199111143252004.
108. Urso, G. (1967). [Effect of Vaccinium myrtillus anthocyanosides associated with betacarotenes on light sensitivity]. Ann. Ottalmol. Clin. Ocul. 93, 930-938.
109. van Reyk, D. M., Gillies, M. C., and Davies, M. J. (2003). The retina: oxidative stress and diabetes. Redox Rep. 8, 187-192. doi: 10.1179/135100003225002673.
110. Varma, S. D. (1991). Scientific basis for medical therapy of cataracts by antioxidants. Am. J. Clin. Nutr. 53, 335S-345S.
111. Varma, S. D., and Hegde, K. R. (2007). Susceptibility of the ocular lens to nitric oxide: implications in cataractogenesis. J. Ocul. Pharmacol. Ther. 23, 188-195. doi: 10.1089/jop.2006.0124.
112. Wielgus, A. R., and Sarna, T. (2008). Ascorbate enhances photogeneration of hydrogen peroxide mediated by the iris melanin. Photochem. Photobiol. 84, 683-691. doi: 10.1111/j.1751-1097.2008.00341.x.
113. Winkler, B. S., Boulton, M. E., Gottsch, J. D., and Sternberg, P. (1999). Oxidative damage and age-related macular degeneration. Mol. Vis. 5, 32.
114. Wu, D., and Meydani, S. N. (1998). n-3 polyunsaturated fatty acids and immune function. Proc. Nutr. Soc. 57, 503-509. doi: 10.1079/PNS19980074.
115. Wu, G. S., Zhang, J., and Rao, N. A. (1997). Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 38, 1333-1339.
116. Yadav, P., Sarkar, S., and Bhatnagar, D. (1997a). Action of capparis decidua against alloxan-induced oxidative stress and diabetes in rat tissues. Pharmacol. Res. 36, 221-228. doi: 10.1006/phrs.1997.0222.
117. Yadav, P., Sarkar, S., and Bhatnagar, D. (1997b). Lipid peroxidation and antioxidant enzymes in erythrocytes and tissues in aged diabetic rats. Indian J. Exp. Biol. 35, 389-392.
118. Yang, X. L. (2004). Characterization of receptors for glutamate and GABA in retinal neurons. Prog. Neurobiol. 73, 127-150. doi: 10.1016/j.pneurobio.2004.04.002.
119. Yildirim, Z., Ucgun, N. I., and Yildirim, F. (2011). The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration. Clinics (Sao Paulo). 66, 743-746. doi: 10.1590/S1807-59322011000500006.
120. Yucel, I., Akar, Y., Yucel, G., Ciftcioglu, M. A., Keles, N., and Aslan, M. (2005). Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vision Res. 45, 1107-1114. doi: 10.1016/j.visres.2004.11.018.
121. Yue, B. Y. (1996). The extracellular matrix and its modulation in the trabecular meshwork. Surv. Ophthalmol. 40, 379-390. doi: 10.1016/S0039-6257(96)80066-X.
122. Zhao, M., Destache, C. J., Ohia, S. E., and Opere, C. A. (2009). Role of prostanoid production and receptors in the regulation of retinal endogenous amino acid neurotransmitters by 8-isoprostaglandin E2, ex vivo. Neurochem. Res. 34:2170-2180. doi: 10.1007/s11064-009-0013-x.
123. Zhao, M., Destache, C. J., Zhan, G., et al. (2008). Regulation of retinal morphology and posterior segment amino acids by 8-isoprostaglandin E2 in bovine eyes ex vivo. Methods Find. Exp. Clin. Pharmacol. 30, 615-626. doi: 10.1358/mf.2008.30.8.1268857.
124. Zheng, L., and Kern, T. S. (2009). Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front. Biosci. (Landmark Ed) 14, 3974-3987. doi: 10.2741/3505.
125. Zhou, L., Li, Y., and Yue, B. Y. (1999). Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J. Cell. Physiol. 180, 182-189.